Peak Pharmaceuticals Inc. (OTC: PKPH), a leading innovator of non-prescription cannabinoid products for animals through its Canna-Pet business, recently announced the launch of its all new MaxCBD Canna-Biscuits for dogs, which offers up to six times the CBD of its standard Canna-Biscuit product line and features its proprietary hemp-based CBD formulations.

“Our new MaxCBD Canna-Biscuit category will be an interesting test of consumer interest in serving size and ease of use,” said Peak Pharmaceuticals Inc. CEO Soren Mogelsvang in a recent press release announcing the launch of the new MaxCBD Canna-Biscuit product line. “If our limited edition biscuits perform well with consumers, we plan to roll out additional flavors as quickly as possible.”

The limited edition MaxCBD Canna-Biscuits are available in the highly popular Maple Bacon flavor. While the new biscuits are designed for those seeking high CBD content for their pets, the company considers them safe to administer to all breeds of dogs when used as directed. With the latest product addition, the company offers six different biscuit types and several different capsule products designed for pets.

The news come shortly after the company announced the launch of its Canna-Pet™ product line on As a part of Amazon Prime, customers can purchase products with free two-day shipping through Amazon’s impressive distribution network. Management is hoping that the additional distribution will not only accelerate current Canna-Pet sales but also forge a way into a brand new vertical.

Shares of Peak Pharmaceuticals Inc. were trading even in early hours on Thursday, April 2, 2015 following the news release.

Disclaimer: Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: